About

Dr Prashanta Kumar Panda is a Staff Scientist in the Division of Pulmonary & Critical Care Medicine, Washington University in St. Louis School of Medicine, St. Louis, USA. He received his PhD in 2017 from the National Institute of Technology, Rourkela, India, where he investigated autophagy and selective autophagy–dependent cell death in cancer. His research spans cancer metabolism, neurodegenerative disease biology, and human iPSC derived models, with recognized expertise in autophagy, apoptosis, and extracellular vesicle biology. His current work focuses on elucidating the regulatory mechanisms of autophagy and selective autophagy, particularly in the context of immune modulation in end-stage lung diseases. Currently, he serves as an Editorial Board Member for Scientific Reports (Nature Portfolio) and as an Associate Editor for Frontiers in Cell and Developmental Biology and Frontiers in Cell Death. He has also served as a Guest Editor for PLOS ONE and is currently serving as a Guest Editor for a special issue in Cells. In addition, he has served as an Editorial Board Member for Tumor Discovery. He has authored and co-authored 37 publications, including 4 book chapters, in internationally reputed journals like Clinical Cancer Research, Cell Reports, Aging Cell etc. His work has received 2,861 citations (Google Scholar), with an h-index of 26 and an i10-index of 34.

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (37)